2020
DOI: 10.1007/s00393-020-00772-9
|View full text |Cite
|
Sign up to set email alerts
|

Schwangerschaft bei Lupus erythematodes – ein Update

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
11
0
11

Year Published

2022
2022
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(22 citation statements)
references
References 36 publications
0
11
0
11
Order By: Relevance
“…For this paper, the recommendations of relevant medical associations, specialist conferences and institutions on rheumatic disease in persons of child-bearing age with a special focus on lupus erythematosus and antiphospholipid syndrome were reviewed in March 2023 and evaluated to see whether they still reflected current knowledge. The literature included recommendations and statements by the following organizations, institutions and authors: the European League Against Rheumatism (EULAR) 2 , 3 , 4 , the American College of Rheumatology Guideline (ACR) 5 , the 16th International Congress on Antiphospholipid-Antibodies Task Force Report 6 , the British Society for Rheumatology 7 , and the German Society for Rheumatology 8 .…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations
“…For this paper, the recommendations of relevant medical associations, specialist conferences and institutions on rheumatic disease in persons of child-bearing age with a special focus on lupus erythematosus and antiphospholipid syndrome were reviewed in March 2023 and evaluated to see whether they still reflected current knowledge. The literature included recommendations and statements by the following organizations, institutions and authors: the European League Against Rheumatism (EULAR) 2 , 3 , 4 , the American College of Rheumatology Guideline (ACR) 5 , the 16th International Congress on Antiphospholipid-Antibodies Task Force Report 6 , the British Society for Rheumatology 7 , and the German Society for Rheumatology 8 .…”
Section: Methodsmentioning
confidence: 99%
“…Predictors for a poor outcome included higher clinical SLE activity at conception, lupus anticoagulant positivity, non-white ethnicity, taking antihypertensives, and thrombocytopenia. An early history of lupus nephritis (LN) and low C4 complement levels in early pregnancy were independently associated with a risk of renal flare 8 , 12 . A first manifestation of lupus nephritis was rare and occurred in just 2% 12 .…”
Section: Pregnancy and Lupus Erythematosusmentioning
confidence: 99%
See 1 more Smart Citation
“…Alternativmöglichkeiten sind in Tab. 3 aufgeführt, sollten aber aufgrund einer notwendigen individualisierten SLE-Therapie nur in enger Rücksprache mit den betreuenden Nephrologen, Dermatologen oder Rheumatologen eingesetzt werden 75 , 76 .…”
Section: Spezifische Ursachen Des Pr-akiunclassified
“…Hydroxychloroquine is currently the best alternative to maintain remission of SLE and lupus nephritis because of its side-effects profile, lack of risks for fetal malformations or fetal or neonatal toxicity, the improvement in renal long-term outcomes and the up to 50% reduction in congenital heart block in infants born to anti-Ro-positive mothers, H 7174 . Alternative options are listed in Table 3 , but because individualized SLE therapy is essential, these alternatives should only be used after consultation with the treating nephrologist, dermatologist or rheumatologist 75 , 76 .…”
Section: Specific Causes Of Pr-akimentioning
confidence: 99%